Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-24 @ 11:28 PM
NCT ID:
NCT06082856
Eligibility Criteria:
Inclusion Criteria:
* Patient with scheduled surgery under general anesthesia for one of the following: oral, orthopedic, urological, digestive and gynecological surgeries.
* The patient must have given their free and informed consent and signed the consent form
* The patient must be a member or beneficiary of a health insurance plan
Exclusion Criteria:
* The subject is in a period of exclusion determined by a previous study
* The subject is unable to give consent
* It is impossible to give the subject informed information
* The patient is under safeguard of justice or state guardianship
* Patient with a known allergy to dexmedetomidine or other drugs.
* Patient with a contraindication to general anesthesia or outpatient management.
* Patient treated with beta-blocker, ACE inhibitor or ARB2
* Patient with an ASA4 score.
* Patient with HR \< 50 bpm.
* Patient with the following cardiovascular comorbidities: coronary insufficiency, obstructive cardiomyopathy, severe hypertension, ventricular rhythm or conduction disorder.
* Patient with hepatic (prothrombin rate \< 70%, liver enzyme/Bilirubin X 3) and/or renal (clearance \< 50 ml.min) insufficiency.
* Pregnant, parturient or nursing patient
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06082856
Study Brief:
Protocol Section:
NCT06082856